Biology of HIV-1 in women and men

Clinical Obstetrics and Gynecology

Volumn 44, Issue 2, 2001, Pages 137-143

  Burger, Harold ^a,b   Weiser, Barbara ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME;

GENOME; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESPAN; LYMPHOCYTE COUNT; PATHOGENESIS; REVIEW; VIRAL GENETICS; VIRUS LOAD; VIRUS REPLICATION;

CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, NATURAL; MALE; SEX FACTORS; VIRUS REPLICATION;

EID: 0035034895     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200106000-00004     Document Type: Review

References (69)

1. HIV as the cause of AIDS
2. Molecular insights into HIV-1 infection
3. Evolution of human immunodeficiency virus type 1 nucleotide sequence diversity among close contacts
4. Adaptive evolution of HIV-1 during the natural course of infection
5. HIV-1 entry cofactors: Functional cDNA cloning of seven-transmembrane, G protein-coupled receptor
6. Identification of a major coreceptor for primary isolates for HIV-1
7. A dual-tropic, primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
8. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
9. A new classification for HIV-1
10. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
11. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection
12. In vivo evolution of HIV-1 coreceptor usage and sensitivity to chemokine-mediated suppression
13. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates
14. Coreceptor usage of primary human immunodeficiency virus type 1 isolated varies according to biologic phenotype
15. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS
16. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
17. Natural history and immunopathogenesis of HIV-1 disease
18. Changing the natural history of HIV disease
19. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection
20. HIV-1 viremia and influenza
21. Human immunodeficiency virus type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination
22. Host factors and the pathogenesis of HIV-induced disease
23. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1
24. Gender differences in HIV-1 diversity at time of infection
25. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection
26. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure
27. Massive convert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
28. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
29. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients
30. Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency patients with myelopathy: Expression and replication in macrophages
31. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission
32. Maternal plasma human immunodeficiency virus type 1 RNA level: A determinant and projected threshold for mother-to-child transmission
33. Rapid turnover of plasma virions and CD4 lymphocytes in infection
34. Viral dynamics in human immunodeficiency virus type 1 infection
35. Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters
36. Sex differences in HIV-1 viral load and progression to AIDS
37. The association of race and gender with HIV-1 RNA levels and immunologic progression
38. Persistence of HIV-1 transcription in peripheral-blood mononuclear class in patients receiving potent antiretroviral therapy
39. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
40. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy
41. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged antiretroviral therapy
42. Relationship between preexisting viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active antiretroviral therapy
43. Viral load and heterosexual transmission of human immunodeficiency virus type 1
44. Sexual transmission of HIV: Infectiousness and prevention
45. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy
46. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV
47. Human immunodeficiency virus type 1 populations in blood and semen
48. Detection of HIV DNA in cervical and vaginal secretions
49. HIV-1 detection in endocervical swabs and mode of HIV infection
50. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract
51. Human immunodeficiency virus type 1 RNA shedding in the female genital tract
52. Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions
53. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission
54. Shedding of HIV in the genital tract
55. Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1
56. Distinct but related HIV-1 variant populations in genital secretions and blood
57. Genetic characterization of human immunodeficiency virus type-1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission
58. Studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in Kenya
59. Determinants of human immunodeficiency virus type I (HIV-1) shedding in the genital tract of HIV-infected women
60. Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy
61. HIV-1 in the female genital tract and the effect of antiretroviral therapy
62. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA
63. Decay characteristics of HIV-1-infected compartments during combination therapy
64. Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: Implications for timing of antiretroviral therapy
65. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele the CKR5 structural gene
66. The role of mutant CCR5 allele in HIV-1 transmission and disease progression
67. Pediatric HIV infection
68. CCR-5 genotype and resistance to vertical transmission of human immunodeficiency virus type 1